Rinn Pharma & Biopharma researchers have achieved a significant research milestone, with 20 researchers across our partner network named among the world's top 2% of scientists in the 2026 Stanford-Elsevier ranking.
The prestigious ranking recognises the world's most influential researchers based on standardised citation indicators derived from Scopus data. Inclusion places researchers among the top 2% in their respective disciplines worldwide, reflecting the impact, quality and influence of their scientific contributions.
For a rapidly growing research Centre, the recognition of 20 principal investigators is a powerful testament to the calibre of expertise within Rinn Pharma & Biopharma and the strength of its collaborative research model. The achievement demonstrates the Centre's ability to bring together internationally recognised leaders in pharmaceutical and biopharmaceutical research while creating an environment that supports impactful scientific discovery and innovation.
The 20 researchers recognised in the 2026 edition are:
- Professor Mike Zaworotko, University of Limerick
- Professor Damien Thompson, University of Limerick
- Professor Anne MacFarlane, University of Limerick
- Professor Edmond Magner, University of Limerick
- Professor Vivek Ranade, University of Limerick
- Associate Professor Matteo Lusi, University of Limerick
- Associate Professor Soumya Mukherjee, University of Limerick
- Associate Professor Luis Padrela, University of Limerick
- Dr Mehakpreet Singh, University of Limerick
- Professor Brendan Griffin, University College Cork
- Professor Thorfinnur Gunnlaugsson, Trinity College Dublin
- Professor Stephen Connon, Trinity College Dublin
- Professor Anne Marie Healy, Trinity College Dublin
- Professor Marcus Baumann, University College Dublin
- Professor David Brayden, University College Dublin
- Professor Pat Guiry, University College Dublin
- Professor Eliana Souto, University College Dublin
- Professor Denis Dowling, University College Dublin
- Associate Professor Rob Elmes, Maynooth University
- Professor Kevin Kavanagh, Maynooth University
Spanning areas including drug delivery, advanced therapeutics, continuous manufacturing, biopharmaceutical analysis, biomaterials and translational healthcare solutions, the work of these researchers is helping to address some of the most significant challenges facing the global life sciences sector. Their achievements reinforce Rinn Pharma & Biopharma’s position as a leading research centre, driving scientific discovery, fostering collaboration across academia and industry, and delivering innovations that can improve patient outcomes worldwide.
As Rinn Pharma & Biopharma continues to expand its research portfolio and international partnerships, this recognition highlights not only the achievements of individual researchers but also the remarkable progress of a young research centre that is already making a significant contribution to global pharmaceutical and biopharmaceutical innovation. The presence of 20 affiliated researchers in the world's top 2% underlines the depth of expertise within the Rinn network and its growing international reputation for research excellence.




